| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay LG Gordon, KMD Merollini, A Lowe, RJ Chan The Patient-Patient-Centered Outcomes Research 10, 295-309, 2017 | 400 | 2017 |
| Financial toxicity: a potential side effect of prostate cancer treatment among Australian men LG Gordon, SM Walker, MC Mervin, A Lowe, DP Smith, RA Gardiner, ... European journal of cancer care 26 (1), e12392, 2017 | 110 | 2017 |
| Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study SK Chambers, MK Hyde, K Laurie, M Legg, M Frydenberg, ID Davis, ... BMJ open 8 (2), e019917, 2018 | 71 | 2018 |
| Use of low copy number DNA in forensic inference A Lowe, C Murray, P Richardson, R Wivell, P Gill, G Tully, J Whitaker International Congress Series 1239, 799-801, 2003 | 63 | 2003 |
| Men's help‐seeking in the first year after diagnosis of localised prostate cancer MK Hyde, RU Newton, DA Galvao, RA Gardiner, S Occhipinti, A Lowe, ... European journal of cancer care 26 (2), e12497, 2017 | 61 | 2017 |
| Measuring masculinity in the context of chronic disease. SK Chambers, MK Hyde, JL Oliffe, L Zajdlewicz, A Lowe, AC Wootten, ... Psychology of Men & Masculinity 17 (3), 228, 2016 | 51 | 2016 |
| Medical help-seeking for sexual concerns in prostate cancer survivors MK Hyde, L Zajdlewicz, AC Wootten, CJ Nelson, A Lowe, J Dunn, ... Sexual medicine 4 (1), e7-e17, 2016 | 42 | 2016 |
| Defining young in the context of prostate cancer SK Chambers, A Lowe, MK Hyde, L Zajdlewicz, RA Gardiner, D Sandoe, ... American journal of men's health 9 (2), 103-114, 2015 | 41 | 2015 |
| Cost‐effectiveness analysis of multiparametric MRI with increased active surveillance for low‐risk prostate cancer in Australia LG Gordon, R James, HW Tuffaha, A Lowe, J Yaxley Journal of Magnetic Resonance Imaging 45 (5), 1304-1315, 2017 | 30 | 2017 |
| Estimating the healthcare costs of treating prostate cancer in Australia: a Markov modelling analysis LG Gordon, HW Tuffaha, R James, AT Keller, A Lowe, PA Scuffham, ... Urologic Oncology: Seminars and Original Investigations 36 (3), 91. e7-91. e15, 2018 | 23 | 2018 |
| Advocacy, support and survivorship in prostate cancer J Dunn, C Casey, D Sandoe, MK Hyde, MC Cheron‐Sauer, A Lowe, ... European Journal of Cancer Care 27 (2), e12644, 2018 | 22 | 2018 |
| TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects … D Wittmann, A Mehta, L Northouse, R Dunn, T Braun, A Duby, L An, ... BMC cancer 17, 1-13, 2017 | 21 | 2017 |
| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient 10: 295–309 LG Gordon, KMD Merollini, A Lowe, RJ Chan | 16 | 2017 |
| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient 10 (3): 295–309 LG Gordon, KMD Merollini, A Lowe, RJ Chan | 16 | 2017 |
| Financial toxicity-what it is and how to measure it LG Gordon, KMD Merollini, A Lowe, RJ Chan Cancer Forum 41 (2), 30-35, 2017 | 14 | 2017 |
| ProsCare: A psychological care model for men with prostate cancer SK Chambers, J Dunn, M Lazenby, S Clutton, RU Newton, P Cormie, ... Prostate Cancer Foundation of Australia, 2013 | 13 | 2013 |
| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient. 2017; 10 (3): 295-309 LG Gordon, KMD Merollini, A Lowe, RJ Chan | 13 | |
| Prostate cancer information needs of Australian gay and bisexual men WK Wong, A Lowe, GW Dowsett, D Duncan, D O'Keefe, A Mitchell Prostate Cancer Foundation of Australia, 2013 | 10 | 2013 |
| A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. The Patient-Patient-Centered Outcomes Res 10 (3): 295–309 LG Gordon, KMD Merollini, A Lowe, RJ Chan | 8 | 2017 |
| New therapies for advanced cancers: can our society afford them A Lowe, S Dyson Is it ethical to deny patients access to them, 2013 | 8 | 2013 |
M HydeThe University of QueenslandVerified email at uq.edu.au
